Back

Stroke prevention in atrial fibrillation and MACE after acute coronary syndrome: prevalence and challenges

29 August 2025 (10:02 - 10:12)
Organised by: Logo
Congress Presentation Part of: Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies Stroke Prevention Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Davide Capodanno

University of Catania, Catania (Italy)

5 More presentations in this session

Presentation thumbnail
Welcome
Professor C. Lam (Singapore, SG)
Video
Presentation thumbnail
Current treatments in atrial fibrillation and acute coronary syndrome, safety and guidelines
Doctor S. Jain (Palo Alto, US)
Slides Video
Presentation thumbnail
Targeting factor XI: innovations in anticoagulation
Doctor J. Weitz (Hamilton, CA)
Slides Video
Presentation thumbnail
Shaping clinical practice and clinical trials
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Audience Q&A and closing remarks
Professor D. Capodanno (Catania, IT) Doctor S. Jain (Palo Alto, US) Doctor J. Weitz (Hamilton, CA) Professor C. Lam (Singapore, SG)

Access the full session

Session thumbnail
Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 10:02 CET
You may be interested in
thumbnail
Congress Session
Optimising atrial fibrillation detection and management in people after stroke
1 September 2025
thumbnail
Congress Session
How to reduce bleeding risk in the acute cardiac care setting: focus on antithrombotic treatment
18 March 2022
thumbnail
Congress Presentation
State-of-the-art lecture in Toward better risk stratification for stroke prevention in atrial fibrillation.
27 August 2022
thumbnail
Congress Presentation
The crossroads in atrial fibrillation management: challenging clinical comfort zones and the future of FXIa
14 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources